Chicago-based Narrative Science is a national leader in the use of artificial intelligence to analyze data and produce compelling narrative stories. The company started as intelligence research project at Northwestern University and has quickly grown into an industry innovator that helps enterprise companies use the power of storytelling to drive better business decisions.
The company’s popular Quill platform is a breakthrough in AI, and is capable of taking complex data, analyzing the relationships and attributes of and among the data, and generating a finished narrative that uses natural language and story structure to produce an in-depth analysis of the underlying data.
Innovation is core to the company, and Narrative Science has secured 17 patents since 2010. In 2015, the company also faced patent infringement litigation brought by a Florida media company called O2 Media, LLC.
Thompson Coburn’s intellectual property team has represented Narrative Science in nearly all of its patent prosecution and litigation efforts. Working seamlessly with the company’s leadership and software engineers, our attorneys dive into the underlying technology and craft customized, forward-looking patent applications that protect Narrative Science’s innovations and allows the company to continue its AI advancements.
Our IP litigators represented Narrative Science in the patent infringement action brought in the Northern District of Illinois, securing in 2016 a full dismissal of the plaintiff’s case, in a decision that invalidated all claims of every patent the plaintiff asserted against Narrative Science in the case. The court also rejected and dismissed, with prejudice, the state’s unfair competition claims the plaintiff asserted.
Our attorneys also have been instrumental in negotiating technology license agreements on behalf of Narrative Science that license the company’s innovative technology to third parties for use in their businesses.
Although we would like to hear from you, we cannot represent you until we know that doing so will not create a conflict of interest. Also, we cannot treat unsolicited information as confidential. Accordingly, please do not send us any information about any matter that may involve you until you receive a written statement from us that we represent you (an ‘engagement letter’).
By clicking the ‘ACCEPT’ button, you agree that we may review any information you transmit to us. You recognize that our review of your information, even if you submitted it in a good faith effort to retain us, and, further, even if you consider it confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you. Please click the ‘ACCEPT’ button if you understand and accept the foregoing statement and wish to proceed.